cefuroxime has been researched along with Bartonella bacilliformis Infection in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Safdar, A | 1 |
| McEvoy, PL | 1 |
| Burns, RG | 1 |
| Perfect, JR | 1 |
1 other study available for cefuroxime and Bartonella bacilliformis Infection
| Article | Year |
|---|---|
Clinical microbiological case: severe relapsing septal panniculitis in a healthy man from the south-eastern USA.
Topics: Acetylcholinesterase; Adult; Animals; Anti-Bacterial Agents; Bartonella henselae; Bartonella Infecti | 2002 |